Source document
Loading document…
KPIsSections2
Sections in this filing
Financial Statements
Item 8.01 Other Events. On August 11, 2026, enGene Therapeutics Inc. (the “Company”) hosted a virtual key opinion leader (“KOL”) event to discuss emerging non-muscle invasive bladder cancer market research insights. A copy of the KOL presentation is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and the full text of the presentation is incorporated herein by reference.